Nanomedicine News

RSS

Research on Laser Therapy Technique Using Nanoparticles to Destroy Tumors

A group of researchers from Wake Forest University Baptist Medical Center is developing a way to treat cancer by using lasers to light up tiny nanoparticles and destroy tumors with the ensuing heat. Today at the 52nd ...

22 Jul 2010

American Society for Nanomedicine to Hold Second Annual Conference

There is enormous excitement and expectation surrounding the multidisciplinary field of nanomedicine – the science and technology of diagnosing, treating and preventing disease using nanotechnology. Nanomedicine is...

22 Jul 2010

Institute of Microelectronics and Stanford University to Develop Silicon Nanowire Based Circuits Inspired by the Brain

The Institute of Microelectronics (IME), a research institute of the Agency for Science, Technology and Research (A*STAR), today announced a collaborative partnership with Stanford University to develop silicon nanowire based circuits that are inspired by the brain.

20 Jul 2010

Stevens Researchers Receive Significant NSF Funding for Nanotechnology Research

Dr. Woo Young Lee of the Chemical Engineering and Materials Science department along with Dr. Hongjun Wang of Chemistry, Chemical Biology and Biomedical Engineering at Stevens Institute of Technology have recently receiv...

20 Jul 2010

Presentation on Study Results of NanoViricides Anti-Ebola Agents

NanoViricides, Inc. reports that the results of the evaluation of several of its nanoviricides® anti-Ebola agents were presented July 17th at the Annual Meeting of the American Society for Virology, July 17-21, at Montana State University, Bozeman, MT. Dr. Corinne Scully delivered the presentation, which was entitled “Polymeric Micelle Nanomaterials as Antiviral Compounds For Ebola Virus Infection.”

From NanoViricides, Inc 20 Jul 2010

DCU Receives Funding for Construction of Nano-Bioanalytical Research Facility

DCU has been awarded €23.8m in Cycle V PRTLI, following an announcement earlier today by An Taoiseach, Brian Cowen.

19 Jul 2010

Genetic Immunity Releases Phase II Study Result of DermaVir Nanomedicine

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria.

19 Jul 2010